Lmr Partners LLP Verona Pharma PLC Transaction History
Lmr Partners LLP
- $9.66 Billion
- Q4 2024
A detailed history of Lmr Partners LLP transactions in Verona Pharma PLC stock. As of the latest transaction made, Lmr Partners LLP holds 48,500 shares of VRNA stock, worth $3.3 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
48,500Holding current value
$3.3 Million% of portfolio
0.02%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding VRNA
# of Institutions
218Shares Held
70.5MCall Options Held
1.4MPut Options Held
299K-
Perceptive Advisors LLC New York, NY6.39MShares$434 Million9.9% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$380 Million18.53% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$230 Million9.42% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.13MShares$213 Million2.79% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx3.13MShares$213 Million2.81% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $4.14B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...